At the BioPharma Asia Convention 2015, James Garner, head of the unit development office for Asia-Pacific at Sanofi gave us some insights on therapeutic discoveries and trials in Asia.
We asked him some key questions:
More and more pharms are seeing Asia as a lucrative site. What are some advantages offered in Asia that more of our US and European partners should take note of?
Many of the Asian Biotechs here today are focusing on either vaccines or oncology. Based on your personal experience, what are some therapeutics areas that are up and coming in Asia? (e.g. CNS, rare disease, tropical diseases?
What are some incentives/ area of improvement the governments can work on to promote more early stage trials in Asia?
Visit the website: http://www.terrapinn.com/biopharma-asia
Read our blog: http://blogs.terrapinn.com/total-biop...
Follow us on Twitter: / totalbiopharma
Join us on LinkedIn: http://www.linkedin.com/groups?home=&...